25.09.2012 Views

TAILORING DRY POWDER INHALER PERFORMANCE BY - RCPE

TAILORING DRY POWDER INHALER PERFORMANCE BY - RCPE

TAILORING DRY POWDER INHALER PERFORMANCE BY - RCPE

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Tailoring Dry Powder Inhaler Performance 769<br />

90 ◦ C, and 8.9 mg for formulations containing mannitol<br />

120 ◦ C.<br />

In addition, the uniformity of dosing was evaluated by<br />

calculating the coefficient of variation of the mass of each<br />

batch (A, B, C). The mean and the standard deviation<br />

of the three coefficients of variation of each formulation<br />

(mannitol 60 ◦ C, 90 ◦ C, 120 ◦ C) were calculated. The coefficients<br />

of variation are given in Fig. 4. Despite the differences<br />

in surface topography, there is no significant difference<br />

between the formulations, the coefficient of variation<br />

showing values of 27.1% for ordered mixtures with<br />

mannitol 60 ◦ C, 36.2% for ordered mixtures with mannitol<br />

90 ◦ C, and 21.3% for ordered mixtures with mannitol<br />

120 ◦ C. Therefore, even if there was a difference of the<br />

flowability of the pure carriers prior to mixing of the carriers<br />

with the active, the attachment of the drug particles to<br />

variation coefficient of the mass / %<br />

50,0<br />

40,0<br />

30,0<br />

20,0<br />

10,0<br />

the carrier surface must have influenced the surface properties<br />

to such an extent that a similar powder flowability<br />

and dosing was finally obtained.<br />

3.4 Delivered Dose<br />

The delivered dose is defined by the dose of active delivered<br />

to the patient by the inhalation device. In this study,<br />

it was determined by discharging 10 doses from the Novolizer<br />

multidose inhaler using the experimental setup described<br />

in the European Pharmacopoeia (Ph. Eur., 2008b).<br />

In contrast to what is described in Pharmacopoeia, 10<br />

subsequent doses were examined, each consisting of five<br />

puffs in order to ensure the proper quantification of the<br />

drug. The dose of active delivered was determined by<br />

HPLC (Fig. 5).<br />

0,0<br />

Mannitol 60°C Mannitol 90°C Mannitol 120°C<br />

FIG. 4: Variation coefficient of the metered mass of 50 single doses of formulations containing mannitol carrier<br />

particles spray dried at 60◦C, 90◦C, and 120◦C; n = 3, mean ± standard deviation.<br />

delivered dose / µg<br />

0<br />

0<br />

0<br />

0 1 2 3 4 5 6 7 8 9 10<br />

number of the dose discharged<br />

FIG. 5: Delivered dose of three batches of each formulation containing mannitol carrier particles spray dried at 60◦C, 90◦C, and 120◦C. Volume 20, Number 9, 2010<br />

Begell House Digital Library, http://dl.begellhouse.com Downloaded 2011-3-4 from IP 129.27.117.213 by Technische Universitaet Graz<br />

Mannitol<br />

120 °C<br />

Mannitol<br />

90 °C<br />

Mannitol<br />

60 °C

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!